RCC1 and glioblastoma: In pancreatic cancer, RCC1 silencing sensitizes tumors to gemcitabine[17], while in glioblastoma, methylation at arginine 214 (R214) of RCC1 reduces RanGTP levels, enhancing radiosensitivity[25].